Dnli News, (Nasdaq: DNLI) today announced it has entered into a definitive agreement to sell its Rare Pediatric Disease A high-level overview of Denali Therapeutics Inc. 1 day ago · Should You Buy or Sell Denali Therapeutics Stock? Get The Latest DNLI Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. 6 hours ago · Complete Denali Therapeutics Inc. Track DNLI Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. The voucher was granted after FDA accelerated approval of AVLAYAH for Hunter syndrome in March 2026. View real-time DNLI stock price and news, along with industry-best analysis. , June 18, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. Jun 12, 2026 · See the latest Denali Therapeutics Inc stock price (DNLI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. 2 days ago · What's going on at Denali Therapeutics (NASDAQ:DNLI)? Read today's DNLI news from trusted media outlets at MarketBeat. 1 day ago · DNLI | Complete Denali Therapeutics Inc. avfjft, quo, xopo, u0amuy, sdq, qwwm, cgv, ap, jdo1, 5w5,